Chemoinformaics analysis of 1-Hydroxy-3,7-dimethoxyxanthone
| Molecular Weight | 272.256 | nRot | 2 |
| Heavy Atom Molecular Weight | 260.16 | nRig | 17 |
| Exact Molecular Weight | 272.068 | nRing | 3 |
| Solubility: LogS | -3.848 | nHRing | 1 |
| Solubility: LogP | 3.413 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 16 |
| nHA | 5 | APOL | 37.0615 |
| nHD | 1 | BPOL | 18.1145 |
| QED | 0.726 |
| Synth | 2.08 |
| Natural Product Likeliness | 0.831 |
| NR-PPAR-gamma | 0.837 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.106 |
| Pgp-sub | 0.042 |
| HIA | 0.007 |
| CACO-2 | -4.819 |
| MDCK | 0.0000273 |
| BBB | 0.053 |
| PPB | 0.885957 |
| VDSS | 0.866 |
| FU | 0.109605 |
| CYP1A2-inh | 0.978 |
| CYP1A2-sub | 0.959 |
| CYP2c19-inh | 0.825 |
| CYP2c19-sub | 0.302 |
| CYP2c9-inh | 0.656 |
| CYP2c9-sub | 0.946 |
| CYP2d6-inh | 0.76 |
| CYP2d6-sub | 0.928 |
| CYP3a4-inh | 0.626 |
| CYP3a4-sub | 0.216 |
| CL | 3.706 |
| T12 | 0.345 |
| hERG | 0.03 |
| Ames | 0.704 |
| ROA | 0.096 |
| SkinSen | 0.804 |
| Carcinogencity | 0.079 |
| EI | 0.979 |
| Respiratory | 0.511 |
| NR-Aromatase | 0.555 |
| Antiviral | Yes |
| Prediction | 0.715144 |